Negri Giovanni, Menia Erica, Egarter-Vigl Eduard, Vittadello Fabio, Mian Christine
Department of Pathology, General Hospital of Bolzano, Bolzano, Italy.
Cancer. 2003 Dec 25;99(6):342-5. doi: 10.1002/cncr.11856.
The purpose of the current study was to compare the efficacy of liquid-based cytology and conventional smears in the cytologic follow-up of cases with "atypical squamous cells, cannot exclude a high-grade lesion" (ASC-H) or "atypical glandular cells" (AGC).
Cytologic follow-up was performed on 214 cases with ASC-H/AGC diagnosis an conventional smears using either ThinPrep (n = 100) or conventional Papanicoloau (Pap) tests (n = 114). Results were then compared with further histologic and/or cytologic follow-up.
Repetition on conventional smears enabled a definite diagnosis (within normal limits [WNL], squamous intraepithelial lesion [SIL] or carcinoma) in 58 cases (50.9%). ASC/AGC was confirmed in 50 cases (43.9%), and 6 of the smears (5.3%) were inadequate. WNL, SIL, or carcinoma was diagnosed in 82 (82.0%) cases by following the patients with ThinPrep cytology, whereas ASC or AGC was confirmed in 18 cases (18.0%). No inadequate specimens were found. A diagnosis of SIL or greater (SIL +) was confirmed histologically in 11 of 11 (100.0%) conventional smears and in 31 of 34 (91.2%) ThinPrep specimens. Of the 87 WNL specimens, 9 (8 conventional smears and 1 ThinPrep specimen) developed a histologically confirmed SIL during further follow-up. Specimen adequacy was significantly better in the ThinPrep specimens compared with conventional smears.
Because of better specimen adequacy, ThinPrep cervical cytology appears to significantly reduce the occurrence of ASC/AGC compared with conventional Pap smears.
本研究的目的是比较液基细胞学和传统涂片在“非典型鳞状细胞,不能排除高级别病变”(ASC-H)或“非典型腺细胞”(AGC)病例的细胞学随访中的效果。
对214例诊断为ASC-H/AGC的病例进行传统涂片的细胞学随访,其中使用ThinPrep(n = 100)或传统巴氏(Pap)试验(n = 114)。然后将结果与进一步的组织学和/或细胞学随访结果进行比较。
对传统涂片进行复查后,58例(50.9%)获得明确诊断(在正常范围内[WNL]、鳞状上皮内病变[SIL]或癌)。50例(43.9%)确诊为ASC/AGC,6例涂片(5.3%)不满意。通过对ThinPrep细胞学检查的患者进行随访,82例(82.0%)诊断为WNL、SIL或癌,而18例(18.0%)确诊为ASC或AGC。未发现不满意标本。11例传统涂片中有11例(100.0%)、34例ThinPrep标本中有31例(91.2%)经组织学确诊为SIL或更高级别(SIL+)。在87例WNL标本中,9例(8例传统涂片和1例ThinPrep标本)在进一步随访中出现组织学确诊的SIL。与传统涂片相比,ThinPrep标本的标本满意度明显更高。
由于标本满意度更高,与传统巴氏涂片相比,ThinPrep宫颈细胞学检查似乎能显著降低ASC/AGC的发生率。